Stay updated with breaking news from Tim Oldham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Roots Analysis has announced the addition of "Cell Therapy Manufacturing Market (5th Edition), 2022-2035" report to its list of offerings. Over...
AdAlta Limited , the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be... -Today at 07:35 am- MarketScreener
AdAlta Ltd (ASX:1AD) CEO Tim Oldham tells Proactive the company has successfully dosed the first participants in its AD-214 Phase I extension study, marking...
AdAlta Ltd (ASX:1AD) has successfully dosed the first participants in its AD-214 Phase I extension study, marking the next milestone in the drug's...
AdAlta Ltd (ASX:1AD) CEO Tim Oldham tells Proactive the company has raised $1.87 million through an oversubscribed shortfall facility. The cash flow comes...